Gheeyoung Choe

Prof. Dr. Gheeyoung Choe


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
HLHye Seung Lee
Hye Seung Lee
KPKyoung Un Park
Kyoung Un Park
JPJung Ok Park
Jung Ok Park
HCHo Eun Chang
Ho Eun Chang
JSJunghan Song
Junghan Song
GCGheeyoung Choe
Gheeyoung Choe

13 September 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
KLKyu Sang Lee
Kyu Sang Lee
YKYoonjin Kwak
Yoonjin Kwak
KNKyung Han Nam
Kyung Han Nam
DKDuck-Woo Kim
Duck-Woo Kim
SKSung-Bum Kang
Sung-Bum Kang
HLHye Seung Lee
Hye Seung Lee
The purpose of our research was to determine the prognostic impact and clinicopathological feature of c-MYC and β-catenin overexpression in colorectal cancer (CRC) patients. Using immunohistochemistry (IHC), we measured the c-MYC and β-catenin expression in 367 consecutive CRC patients retrospectively (cohort 1). Also, c-MYC expression was measured by mRNA in situ hybridization. Moreover, to analyze regional heterogeneity, three sites of CRC including the primary, distant and lymph node metastasis were evaluated in 176 advanced CRC patients (cohort 2). In cohort 1, c-MYC protein and mRNA overexpression and ß-catenin nuclear expression were found in 201 (54.8 %), 241 (65.7 %) and 221 (60.2 %) of 367 patients, respectively, each of which was associated with improved prognosis (P = 0.011, P = 0.012 and P = 0.033, respectively). Moreover, co-expression of c-MYC and ß-catenin was significantly correlated with longer survival by univariate (P = 0.012) and multivariate (P = 0.048) studies. Overexpression of c-MYC protein was associated with mRNA overexpression (ρ, 0.479; P < 0.001) and nuclear ß-catenin expression (ρ, 0.282; P < 0.001). Expression of c-MYC and ß-catenin was heterogeneous depending on location in advanced CRC patients (cohort 2). Nevertheless, both c-MYC and ß-catenin expression in primary cancer were significantly correlated with improved survival in univariate (P = 0.001) and multivariate (P = 0.002) analyses. c-MYC and ß-catenin expression of lymph node or distant metastatic tumor was not significantly correlated with patients’ prognosis (P > 0.05). Co-expression of c-MYC and ß-catenin was independently correlated with favorable prognosis in CRC patient. We concluded that the expression of c-MYC and ß-catenin might be useful predicting indicator of CRC patient’s prognosis.

16 November 2017 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KLKyu Sang Lee
Kyu Sang Lee
KLKyoungyul Lee
Kyoungyul Lee
SYSumi Yun
Sumi Yun
SMSeyoung Moon
Seyoung Moon
YPYujun Park
Yujun Park
GCGheeyoung Choe
Gheeyoung Choe

15 January 2015 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
SYSumi Yun
Sumi Yun
JKJae Moon Koh
Jae Moon Koh
KLKyu Sang Lee
Kyu Sang Lee
ASAn Na Seo
An Na Seo
KNKyung Han Nam
Kyung Han Nam
GCGheeyoung Choe
Gheeyoung Choe
Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have been reported to be involved in cancer invasion. We examined the immunohistochemical expression of c-MET and HGF in 100 cases of patients with meningiomas who have undergone complete tumor removal. c-MET(-High) and HGFHigh were found in 17% and 13% of meningiomas, respectively. Brain invasion was observed in 17.6% of c-MET(-High) meningiomas, but in only 2.4% of c-MET(-Low) meningiomas (p=.033). Bone/soft tissue invasion was observed in 23.5% of c-MET(-High) meningiomas and in 9.6% of c-MET(-Low) meningiomas (p=.119). HGF(-High) did not show statistical association with brain invasion or bone/soft tissue invasion. c-MET(-High) demonstrated shorter recurrence-free survival (RFS, 93.5±8.2 months vs 96.1±1.9 months); however, this difference was not statistically significant (p=.139). There was no association of HGF(-High) with RFS. This study demonstrates that c- MET(-High) is associated with brain invasion of meningiomas, and that c-MET expression may be a useful predictive marker for meningioma recurrence. Patients with invasive meningiomas with high expressions of c-MET may be good candidates for targeted therapy using c-MET inhibitors.

1 January 2013 in The Korean Journal of Pathology
Verified
Journal Article
Open access
PDF file
KLKyu Sang Lee
Kyu Sang Lee
GCGheeyoung Choe
Gheeyoung Choe
KNKyung Han Nam
Kyung Han Nam
ASAn Na Seo
An Na Seo
SYSumi Yun
Sumi Yun
SPSung Hye Park
Sung Hye Park
Lee KS, et al. Korean J Pathol. 2013 Dec;47(6):541-548. http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541

1 January 1994 in The Korean Journal of Parasitology
Verified
Journal Article
Open access
PDF file
SHSung-Tae Hong
Sung-Tae Hong
YKYoung Tae Kim
Young Tae Kim
GCGheeyoung Choe
Gheeyoung Choe
YMY I Min
Y I Min
SCS H Cho
S H Cho
SLS H Lee
S H Lee
Hong ST, et al. Korean J Parasitol. 1994 Mar;32(1):43-48. http://dx.doi.org/10.3347/kjp.1994.32.1.43